Comerica Bank’s Pulmonx LUNG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
$40 Sell
18
-24
-57% -$45 ﹤0.01% 3696
2025
Q3
$68 Hold
42
﹤0.01% 3694
2025
Q2
$109 Hold
42
﹤0.01% 3669
2025
Q1
$283 Sell
42
-182
-81% -$1.29K ﹤0.01% 3632
2024
Q4
$1.52K Hold
224
﹤0.01% 3522
2024
Q3
$1.86K Buy
224
+182
+433% +$1.32K ﹤0.01% 3505
2024
Q2
$266 Sell
42
-333
-89% -$2.56K ﹤0.01% 3655
2024
Q1
$3.48K Hold
375
﹤0.01% 3413
2023
Q4
$4.78K Hold
375
﹤0.01% 3332
2023
Q3
$3.87K Buy
+375
New +$4.34K ﹤0.01% 3433

Other funds holding LUNG

Comerica Bank's LUNG Position: Q4 2025 in Review

Comerica Bank reduced its Pulmonx (LUNG) stake by 57% in Q4 2025, selling an estimated $45 and leaving 18 shares worth $40. The position accounts for ﹤0.01% of the portfolio, ranked #3696.

Comerica Bank first reported a position in LUNG in Q3 2023 and has held it in 10 quarters since. The position peaked at $4.78K in Q4 2023. 112 funds tracked by Wall St. Rank hold LUNG as of Q4 2025.

  • Comerica Bank held 18 shares of Pulmonx worth $40 as of Q4 2025.
  • Comerica Bank sold 24 Pulmonx shares in Q4 2025, an estimated $45.
  • Pulmonx made up ﹤0.01% of Comerica Bank's portfolio in Q4 2025, its #3696 holding.
  • Comerica Bank first reported a position in Pulmonx in Q3 2023 and has held it in 10 quarters since.
  • Comerica Bank's Pulmonx position peaked at $4.78K in Q4 2023.
  • 112 funds tracked by Wall St. Rank held Pulmonx as of Q4 2025.

Based on Comerica Bank's 13F filing for Q4 2025, filed 29 Jan 2026.